[27P2-pm2] Clinical Pharmacy 3

[27P2-pm2-124S] Irinotecan-induced severe hypotension in a patient with lung cancer

○Ryota Nakano¹, Kenji Momo², Airi Matsuzaki², Akiko Sakai³, Takeshi Uchikura², Katsumi Tanaka², Satoshi Numazawa¹, Tadanori Sasaki⁴ (1. Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa University School of Pharmacy, Tokyo, Japan, 2. Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan, 3. Department of Pharmacy, Izumi Memorial Hospital, Tokyo, Japan, 4. Appropriate Medication Therapy Management (MTM), School of Pharmacy, Showa University, Tokyo, Japan)